|||FREE||| Obstetrics and Gynecology

Total Page:16

File Type:pdf, Size:1020Kb

|||FREE||| Obstetrics and Gynecology OBSTETRICS AND GYNECOLOGY FREE DOWNLOAD Charles R. B. Beckmann,William N.P. Herbert,Douglas W. Laube,Frank Ling,Roger P. Smith | 528 pages | 21 Mar 2013 | Lippincott Williams and Wilkins | 9781451144314 | English | Philadelphia, United States Register for a free account We are grateful for the outstanding care she has provided to our patients. Connect with us on social media! August Learn how and when to remove this template message. Read more. Our providers recommend these 6 helpful tips for reducing your period pain. I haven't seen someone like that in a long time and it was such a Obstetrics and Gynecology surprise. Call us or email us with any questions or to schedule your visit. Chorionic villus sampling Amniocentesis Triple test Quad test Fetoscopy Fetal scalp blood testing Fetal scalp stimulation test Percutaneous umbilical cord blood sampling Apt test Kleihauer—Betke test Lung maturity Lecithin—sphingomyelin ratio Lamellar body count Fetal fibronectin test. Get Obstetrics and Gynecology touch. Wellness and Integrative Care. From pre-conception Now Accepting New Patients Schedule an appointment today. I was in and out in the shortest time possible. Some procedures may include: [8]. Your Partner For a Lifetime of Care. Experienced OB-GYN professionals can seek certifications in sub-specialty areas, including maternal and fetal medicine. You can rest easy knowing that one of our physicians is always on call, 24 hours a day, to deliver your baby. Are you accepting new patients? Imaging Obstetric ultrasonography Nuchal scan Anomaly scan Fetal movement counting Contraction stress test Nonstress test Vibroacoustic stimulation Biophysical profile Amniotic fluid index Umbilical artery dopplers. They are all strong confident women and immediately made me feel like I was in good hands. Gynecological Care for Women of All Ages. Namespaces Article Talk. What Makes Obstetrics and Gynecology Practice Unique? In- Office Procedures. Pregnancy test Leopold's maneuvers Prenatal testing. Words from our patients. Can't ask for more! Elaine W. In-Office Laboratory Testing. Monday am - pm Tuesday am - pm Wednesday am - Obstetrics and Gynecology Thursday am - pm Friday am - pm Saturday Closed Sunday Closed. We care for all of your gynecology needs. We tailor that compassionate, inclusive care to you. Always Obstetrics and Gynecology, informative, and treated very well. Expert and Compassionate Prenatal Care. Postgraduate training programs for both fields are usually combined, preparing the practicing obstetrician-gynecologist to be adept both at the care of female reproductive organs' health and at the management of pregnancy, although many doctors go on Obstetrics and Gynecology develop subspecialty interests in one field or the other. Menopause and perimenopause, preconception, and contraception counseling are just a few of the concerns that are well-suited to being addressed with a video visit. We perform surgery at Highland Hospital. Wikimedia Commons. I had an Obstetrics and Gynecology c section and difficult recovery, but I knew I was in Obstetrics and Gynecology hands. Healthcare for Women, by Women. Mosmen is an extremely knowledgeable, dedicated and compassionate doctor. Then they must complete a two years of foundation training. The staff was friendly and professional! You may improve this articlediscuss the issue on the talk pageor create a new articleas appropriate. Artificial rupture of membranes Episiotomy Symphysiotomy Forceps in childbirth Ventouse Obstetrics and Gynecology childbirth Odon device. Gynecology We care for all of your gynecology needs. Call us today to book an appointment To assure proper social distancing, unscheduled walk-ins for lab tests may no longer be accommodated. Office Hours. Our team of physicians at OBGYN Westside offers the full spectrum of gynecological care from Obstetrics and Gynecology wellness exams to management of complex gynecologic conditions. I am forever grateful for these doctors at this practice! She will be greatly missed and we wish her all the best. Following this, they are eligible for provisional registration with the General Medical Council. Specializing in Women's Healthcare. But some gynecological conditions can interfere with pregnancy. Views Read Edit View history. Experts in minimally invasive laparoscopy and Davinci robot-assisted surgery. At RGOA, we Obstetrics and Gynecology committed to excellence in health care for women. Which insurance plans do you accept? American Osteopathic Board of Obstetrics and Gynecology. From Wikipedia, the free encyclopedia. Read less. It can sometimes take months for a woman to conceive. Vaginal delivery Induction Artificial Obstetrics and Gynecology of membranes Episiotomy Symphysiotomy Forceps in childbirth Ventouse in childbirth Odon device. Girls may have their first well-woman visit as early as ages 13 to Providing Healthcare for Women, by Women. https://uploads.strikinglycdn.com/files/0cc7b47d-f033-4e52-bc86-d5cc3d9c750a/demon-road-the-demon-road-trilogy-book-1-79.pdf https://uploads.strikinglycdn.com/files/9d425306-d0c7-4fef-9a01-921ed4c566c5/martin-heidegger-between-good-and-evil-86.pdf https://uploads.strikinglycdn.com/files/6154218d-6828-4122-9db5-4ceb26991215/portent-77.pdf https://cdn.shopify.com/s/files/1/0503/8469/9566/files/case-study-houses-93.pdf https://cdn.shopify.com/s/files/1/0498/5582/4061/files/poison-island-22.pdf https://cdn.shopify.com/s/files/1/0502/3793/1703/files/jesus-feminist-gods-radical-notion-that-women-are-people-too-28.pdf.
Recommended publications
  • ASSIST II Participant Information Leaflet V2.0 07JUL2020.Pdf
    The BD Odon Device™ for assisted vaginal birth: A feasibility study to investigate safety and efficacy The ASSIST II Study Participant Information Leaflet Would you be willing to join us in a research project? Page 1 of 10 ASSIST II Participant Information Leaflet v2.0 (07JUL2020) The ASSIST II Study: A study investigating the use of a device that may be used to assist a baby’s birth We would like to invite you to join us in a research study investigating a new device which may be used to assist your baby’s birth. Before you decide whether you would like to participate, it is important for you to understand why the research is being performed and what it involves. There is also an ASSIST II Study video – the video and this leaflet contain different information so it is important they are used together. You will then be able to ask any questions and be given time to decide if this study is right for you and your baby. Why have I been invited to take part? All women who are pregnant with one baby and are planning a vaginal birth at either Southmead or Cossham Maternity Unit are invited to take part in this study. If you would like to take part, we would like your agreement in principle before labour, just in case you do need assistance with the birth of your baby later on. Do I have to take part? No. It is entirely up to you whether you agree to take part or not. If you decide not to be involved, your care will not be affected in any way.
    [Show full text]
  • Hamilton Radiologu Nuchal Translucencey
    PATIENT INFORMATION Advice regarding your 12 week scan Nuchal Translucency HAMILTON RADIOLOGY MEDICAL IMAGING SPECIALISTS YOU’RE IN SAFE HANDS A Few Facts . • The vast majority of babies are born normal. • All women, whatever their age, have a small risk of delivering a baby with physical and/or intellectual impairment. • In some cases the impairment is due to a chromosome abnormality such as Downs Syndrome (Trisomy 21). • The programme will only accept foetuses with a crown rump length between 4.5 and 8.3cm ie within the 11+2 days – 13 weeks 6 days period. Optimal time for this scan is 12–13 weeks. • The scan gives an estimate of the risk for Downs Syndrome. To know for sure whether or not the foetus has a chromosomal abnormality, an invasive test is needed (chorionic villus sampling or amniocentesis). • However, invasive tests carry a small risk of causing miscarriage (1%). • The early scan allows detection of some, but not all, physical defects. A further scan at 19–20 weeks is recommended. Risk for Downs Syndrome The table to the right shows how the chance of having a baby with Downs Syndrome increases with age. The First Trimester Scan At the 12 week scan we confi rm that the foetus is alive and we assess the gestational age by measuring the crown-rump length. We can look for major physical defects, measure nuchal translucency thickness and calculate your baby’s chance of Downs Syndrome based on the scan fi ndings and your age. Occasionally the foetus is not well seen on the abdominal scan and it may be necessary to perform a transvaginal scan.
    [Show full text]
  • Monoamniotic Twins: What Should Be the Optimal Antenatal Management?
    Monoamniotic Twins: What Should Be the Optimal Antenatal Management? Ashis K. Sau1, Kate Langford1, Catherine Elliott1, Lin L. Su2, and Darryl J. Maxwell1 1Fetal Medicine Unit, St.Thomas’ Hospital, London, UK 2National University Hospital, Singapore onoamniotic twinning is a rare event with an incidence of London with a high proportion of socially deprived and M1% of all monozygotic twins and associated with a high black, Asian or mixed race peoples. Management protocols fetal morbidity and mortality. Confident early diagnosis is possi- ble, but optimal management is not yet established. This article employed were those of early detection of chorionicity and presents the experience of a single centre in managing all amnionicity, 2-weekly serial ultrasound surveillance and monoamniotic twins diagnosed during 1994–2000. Seven pairs early delivery by elective cesarean section at around 32 of monoamniotic twins were identified for analysis. All were weeks gestation. From 1997, a formal twin ultrasound sur- managed in accord with a unit protocol that involved early diag- veillance clinic was established and first trimester nuchal nosis, serial ultrasound examination and elective early delivery. In four cases, the detection of monoamnionicity was made translucency screening was performed. The same fetal med- during a first trimester nuchal scan. Discordance for structural icine consultant had clinical input into the management of abnormality was found in three cases where the co-twin was all cases. A summary of the cases can be seen in Table 1. normal. Cord entanglement was detected antenatally in four cases. Two pairs of twins died before 20 weeks. One of these Case 1 had early onset twin–twin transfusion syndrome.
    [Show full text]
  • FIGURE 1 in Trained Hands, Operative Vaginal Delivery Can Be An
    FIGURE 1 In trained hands, operative vaginal delivery can be an extremely effective intervention to expedite delivery when nonreassuring fetal testing is noted during the second stage of labor. ILLUSTRATION: KIMBERLY MARTENS FOR OBG MANAGEMENT 38 OBG Management | June 2014 | Vol. 26 No. 6 obgmanagement.com UPDATE OPERATIVE VAGINAL DELIVERY New data confirm that the combination of forceps and vacuum extraction should be avoided and demonstrate that use of midcavity rotational forceps is safe and effective ›› Errol R. Norwitz, MD, PhD Dr. Norwitz is Louis E. Phaneuf Professor of Obstetrics and Gynecology, Tufts University School of Medicine, and Chairman of the Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, Massachusetts. Dr. Norwitz serves on the OBG Management Board of Editors. The author reports no financial relationships relevant to this article. he past year has seen the publica- delivery in the setting of transverse arrest, Ttion of four studies with relevance for namely manual rotation, vacuum rota- clinicians: tion, and rotational forceps • a retrospective cohort study that exam- • another retrospective cohort study that ined the maternal risks of operative vaginal compared maternal morbidity among IN THIS ARTICLE delivery using forceps, vacuum extraction operative vaginal deliveries performed by (FIGURE 1), or a combination of forceps midwives and physician providers in the Why you should learn and vacuum United Kingdom to perform midcavity • a prospective cohort study that investi- • a description of a new technique for instru- rotational deliveries gated the efficacy and safety of three dif- mental vaginal delivery that is low-cost, page 40 ferent techniques for midcavity rotational simple, and easy to perform.
    [Show full text]
  • Screening for Trisomy 21 in Denmark; Evaluation of the Current and Possible Future Strategies
    Faculty of Health Sciences University of Copenhagen Screening for trisomy 21 in Denmark; Evaluation of the current and possible future strategies PhD thesis Charlotte Kvist Ekelund Academic supervisors Ann Tabor, professor, DMSc, Department of Fetal Medicine, Rigshospitalet, University of Copenhagen Olav Bjørn Petersen, PhD, consultant, Department of Obstetrics, Aarhus University Hospital Ida Vogel, DMSc, Head of Department of Clinical Genetics, Aarhus University Hospital Evaluation committee Katja Bilardo, Professor, Head Fetal Medicine Unit, Department of Obstetrics & Gynaecology, University Medical Center Groningen, The Netherlands Michael Christiansen, Head of Molecular Diagnostics, Statens Serum Institute, Copenhagen Lone Krebs, DMSc, Associate professor, consultant, Department of Gynecology and Obstetrics, Holbæk Sygehus, University of Copenhagen The PhD defence will take place Friday the 13th of April 2012, Auditorium B, Teilum, Rigshospitalet, Copenhagen. Acknowledgement This thesis was made possible by help from a number of fantastic supervisors and colleagues. First and foremost, I owe my deepest thanks to Professor Ann Tabor. Thank you for sharing your interest and knowledge in first trimester screening with me, for your professional and personal guidance, for always having time and for showing your confidence in me from the very beginning of the project. Your constructive and focused attitude is admirable and to me you have been an extremely inspiring mentor within all aspects of life. I am greatly indebted to Olav Bjørn Petersen, MD, PhD, one of the most enthusiastic and optimistic persons I know. Your positive attitude, support and encouragement have really helped me through the challenging phases of the project. And my sincere thanks to Ida Vogel, MD, DMSc for taking part in the project, for everything you taught me many years ago and for still being there.
    [Show full text]
  • Antenatal Care: Timetable
    Antenatal care: timetable NICE issued guidelines on routine care for the healthy pregnant woman in March 2008. They recommend: 10 antenatal visits in the first pregnancy if uncomplicated 7 antenatal visits in subsequent pregnancies if uncomplicated women do not need to be seen by a consultant if the pregnancy is uncomplicated Gestation Purpose of visit 8 - 12 weeks (ideally < 10 Booking visit weeks) general information e.g. diet, alcohol, smoking, folic acid, vitamin D, antenatal classes BP, urine dipstick, check BMI Booking bloods/urine FBC, blood group, rhesus status, red cell alloantibodies, haemoglobinopathies hepatitis B, syphilis, rubella HIV test is offered to all women urine culture to detect asymptomatic bacteriuria 10 - 13 weeks Early scan to confirm dates, exclude multiple pregnancy 11 - 13+6 weeks Down's syndrome screening including nuchal scan 16 weeks Information on the anomaly and the blood results. If Hb < 11 g/dl consider iron Routine care: BP and urine dipstick 18 - 20+6 weeks Anomaly scan 25 weeks (only if primip) Routine care: BP, urine dipstick, symphysis-fundal height (SFH) 28 weeks Routine care: BP, urine dipstick, SFH Second screen for anaemia and atypical red cell alloantibodies. If Hb < 10.5 g/dl consider iron First dose of anti-D prophylaxis to rhesus negative women 31 weeks (only if primip) Routine care as above 34 weeks Routine care as above Second dose of anti-D prophylaxis to rhesus negative women Information on labour and birth plan 36 weeks Routine care as above Check presentation - offer external cephalic version if indicated Information on breast feeding, vitamin K, 'baby-blues' 38 weeks Routine care as above 40 weeks (only if primip) Routine care as above Discussion about options for prolonged pregnancy 41 weeks Routine care as above Discuss labour plans and possibility of induction 1 Prescribing in pregnant patients Very few drugs are known to be completely safe in pregnancy.
    [Show full text]
  • Curriculum Vitae
    CURRICULUM VITAE Gian Carlo Di Renzo, MD, PhD Professional Address Gian Carlo Di Renzo Professor and Chairman Dept. of Ob/Gyn Director, Centre for Perinatal and Reproductive Medicine Santa Maria della Misericordia University Hospital 06132 San Sisto - Perugia - Italy tel. +39 075 5783829 tel. +39 075 5783231 fax +39 075 5783829 [email protected] Date of birth: 13 June 1951 Place of birth: Verona, Italy Citizenship: Italian 1 Director of Education and Communication & Past General Secretary of FIGO University of Perugia, Perugia, Italy. Prof. Gian Carlo Di Renzo is currently Professor and Chair at the University of Perugia (2004 - ), and Director of the Reproductive and Perinatal Medicine Center (1996 - ) , former Director of the Midwifery School (2004-2016), University of Perugia, in addition to being the Director of the Permanent International and European School of Perinatal and Reproductive Medicine (PREIS) in Florence (2012 - ) . After graduation cum laude at Medical School of the University of Padova (1975) , he was a research fellow at the Universities of Verona, Messina and Modena. After training at CHUV in Lausanne (Switzerland), at UCH in London (UK), at the University of Texas in Dallas (USA), and at the Catholic University in Nijmegen (NL) (1977-1982), he became a senior researcher at the University of Perugia. Since 2004 he is Professor and Chairman of the Department of Obstetrics and Gynecology at the University or Perugia., Chairman of the Midwifery School in the year 2004 to 2016, of the Ob Gyn Resident’s program since 2008 and of the PhD Program in Translational Medicine since 2012. He was general Secretary of the Italian Society of Perinatal Medicine, President of the Italian Society of Ultrasound in Obstetrics and Gynecology, Secretary-Treasurer of the European Association of Perinatal Medicine, President from 2000 to 2002, 2002-2008 Executive Director and Chairman of the Educational Committee, Vice President of the World Association of Perinatal Medicine ( 2007-2013) .
    [Show full text]
  • Downs, Edwards & Pataus Screening Protocol (CG481)
    Down’s, Edwards’ and Pataus syndromes screening protocol (CG481) Approval and Authorisation Approval Group Job Title, Chair of Committee Date Maternity Clinical Governance Chair, Maternity Clinical 4th June 2021 Committee Governance Committee Change History Version Date Author, job title Reason 8.0 Mar 2018 Jo Young, AN screening Reviewed and updated to reflect coordinator current practice 8.1 February J Young, AN screening Live change to update reporting 2019 coordinator body to PHE FASP and adjust working practices in line with this change. 8.2 August J Young, AN screening Live change following PHE Audit 2019 coordinator July 2019 Pg 6 – 5.5 The Combined Test gestation period in which NT scan can take place updated to read 11+2 and 14+1 weeks 9.0 March 2020 J Young, AN screening Reviewed, changes throughout to coordinator reflect current practice pg 5 – 16 and introduction of new MATSOP039 and update of consent form 10.0 May 2021 S Lindsay-Birch, ANNB Live change to reflect process post Screening Specialist MW Go Live and introduction of NIPT from 1/6/21 ................................................................................................................................................................... This protocol should be read in conjunction with the following: • Antenatal Screening protocol (CG474) • MAT-SOP-039 NT daily failsafe (WBCH only) Author: S Lindsay-Birch Date: June 2021 Job Title: ANNB Screening Specialist MW Review Date: June 2023 Policy Lead: Group Director Urgent Care Version: V10.0 Location: Policy hub/ Clinical/ Maternity/ Antenatal/ CG481 This document is valid only on date last printed Page 1 of 19 Maternity guidelines – Downs, Edwards & Pataus syndromes screening protocol (CG481) June 2021 Contents 1.0 Purpose .............................................................
    [Show full text]
  • O'brien, SM, Winter, C., Burden, CA, Boulvain, M., Draycott, TJ
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Explore Bristol Research O'Brien, S. M. , Winter, C., Burden, C. A., Boulvain, M., Draycott, T. J., & Crofts, J. F. (2017). Pressure and traction on a model fetal head and neck associated with the use of forceps, Kiwi™ ventouse and the BD Odon Device™ in operative vaginal birth: a simulation study. BJOG: An International Journal of Obstetrics and Gynaecology, 124(S4), 19-25. https://doi.org/10.1111/1471-0528.14760 Peer reviewed version License (if available): CC BY-NC Link to published version (if available): 10.1111/1471-0528.14760 Link to publication record in Explore Bristol Research PDF-document This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Wiley at http://onlinelibrary.wiley.com/doi/10.1111/1471-0528.14760/abstract. Please refer to any applicable terms of use of the publisher. University of Bristol - Explore Bristol Research General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/pure/about/ebr-terms Pressure and traction on a model fetal head and neck associated with the use of forceps, Kiwi™ ventouse and the BD Odon Device™ in operative vaginal birth: a simulation study Authors Stephen M O’Brien a, b, Cathy Winter a, Christy A Burden a, b, Michel Boulvain d, Tim J Draycott a, c, Joanna F Crofts a, c a Department of Obstetrics
    [Show full text]
  • The Effect of Progesterone Use in the First Trimester on Fetal Nuchal Translucency
    Original Investigation 29 The effect of progesterone use in the first trimester on fetal nuchal translucency Müberra Namlı Kalem1, Ziya Kalem2, Batuhan Bakırarar3, Ali Ergün1, Timur Gürgan2 1Clinic of Obstetrics and Gynecology, Liv Hospital, Ankara, Turkey 2Gürgan Clinic IVF and Women Health Center, Ankara, Turkey 3Department of Biostatistic, Ankara University School of Medicine, Ankara, Turkey Abstract Objective: To evaluate the possible association between progesterone use in the first trimester of pregnancy and fetal nuchal translucency (NT). Material and Methods: This is an observational case-control study, which was conducted with patients who underwent nuchal scans between March 2015 and February 2016 and consequently delivered live and healthy babies. The study group was composed of assisted reproductive technology pregnancies and used intravaginal progesterone 180 mg/day until gestational week 12. The control group comprised pregnant women who became pregnant spontaneously without using any progesterone preparation in the first trimester. Results: One hundred sixty-four (57.5%) of 285 patients were in the control group and 121 (42.5%) were in the progesterone group. Age, bodyweight, gravidity, and parity number of previous births and abortus, gestational week, crown-rump lengths, free β-human chorionic gonadotropin, pregnancy-associated plasma protein A, and NT values of the progesterone and control groups were recorded and we investigated whether there was a statistically significant difference between the two groups in terms of these parameters; maternal weight was found to be higher in the progesterone group than in the control group and the difference between the groups was statistically significant (p=0.019 and p=0.025).
    [Show full text]
  • The Identification and Validation of Neural Tube Defects in the General Practice Research Database
    THE IDENTIFICATION AND VALIDATION OF NEURAL TUBE DEFECTS IN THE GENERAL PRACTICE RESEARCH DATABASE Scott T. Devine A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the School of Public Health (Epidemiology). Chapel Hill 2007 Approved by Advisor: Suzanne West Reader: Elizabeth Andrews Reader: Patricia Tennis Reader: John Thorp Reader: Andrew Olshan © 2007 Scott T Devine ALL RIGHTS RESERVED - ii- ABSTRACT Scott T. Devine The Identification And Validation Of Neural Tube Defects In The General Practice Research Database (Under the direction of Dr. Suzanne West) Background: Our objectives were to develop an algorithm for the identification of pregnancies in the General Practice Research Database (GPRD) that could be used to study birth outcomes and pregnancy and to determine if the GPRD could be used to identify cases of neural tube defects (NTDs). Methods: We constructed a pregnancy identification algorithm to identify pregnancies in 15 to 45 year old women between January 1, 1987 and September 14, 2004. The algorithm was evaluated for accuracy through a series of alternate analyses and reviews of electronic records. We then created electronic case definitions of anencephaly, encephalocele, meningocele and spina bifida and used them to identify potential NTD cases. We validated cases by querying general practitioners (GPs) via questionnaire. Results: We analyzed 98,922,326 records from 980,474 individuals and identified 255,400 women who had a total of 374,878 pregnancies. There were 271,613 full-term live births, 2,106 pre- or post-term births, 1,191 multi-fetus deliveries, 55,614 spontaneous abortions or miscarriages, 43,264 elective terminations, 7 stillbirths in combination with a live birth, and 1,083 stillbirths or fetal deaths.
    [Show full text]
  • Maternity Services Guideline Antenatal Appointments
    MATERNITY SERVICES GUIDELINE ANTENATAL APPOINTMENTS GUIDELINE Version Authors Michala Little - Community Midwifery Manager Kath Chapman – Community Midwifery Team Leader Lynda Fairclough - Community Midwifery Team Leader Owner Michala Little Community Midwifery Manager Date of First issue 1994 Version 12.1 Date of Version issue September 2019 Ratified by York: Obs & Gynae Clinical Scarborough: Obs & Gynae Governance Forum Clinical Governance Forum Date Ratified 12.11.19 12.11.19 Review date September 2021 Version information Significant changes to previous version. Update September 2019 to include aspirin changes, VTE update, proteinurea guidance and safeguarding info Antenatal Appointment Guideline Version No. 12.1 November 2019 – September 2021 Page 1 of 30 Contents Section Title Page 1 Introduction & Scope 3 2 Management 3 2.1 The Booking Process 3 2.2 Criteria for Midwifery Led Care 3 2.3 Criteria for Consultant Review 4 2.4 Criteria for Planned Homebirth 5 2.5 Booking Risk Assessment 6 2.6 Frequency of A/N Visits for Low Risk Women 10 3 Links with 17 4 References 17 Appendices Appendix 1: Referral Flowchart from M/W led Care to Consultant 19 Appendix 2: Procedure for Women Who Attend Antenatal or a Community Clinic without Handheld Pregnancy Records 20 Appendix 3: Procedure for women who do not attend appointments(DNA) 21 Appendix 4: Procedure for women who decline blood products 22 Appendix 5: Procedure for Measuring Symphsis-Fundal Height 23 Appendix 6: High incidence of TB by country 24 Appendix7: Northern and Yorkshire Cleft Lip and Palate service 25 Appendix 8: Flowchart for women recommended to take low dose aspirin 26 Appendix 9: Ante natal payments pathway 27 Appendix 10: Screening for domestic abuse in pregnancy 29 Appendix 11: Pathway of care for women having blood taken for grouping and Antibody Screening’ guideline 30 Antenatal Appointment Guideline Version No.
    [Show full text]